Third Harmonic Bio, Inc. (NASDAQ:THRD) revealed results from its Phase 1 single and multiple ascending dose (SAD/MAD) trial ...
A new phenomenon sweeps the world, but Eian remains clueless until the love of his life, Madison, dumps him. He splits into three extremely emotional versions of himself. Thus, falling victim to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback